scispace - formally typeset
T

Thérèse Lehy

Researcher at French Institute of Health and Medical Research

Publications -  86
Citations -  4700

Thérèse Lehy is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Gastrin & Somatostatin. The author has an hindex of 35, co-authored 86 publications receiving 4561 citations. Previous affiliations of Thérèse Lehy include VU University Amsterdam & Paris Diderot University.

Papers
More filters
Journal ArticleDOI

The stomach is a source of leptin

TL;DR: It is shown that leptin messenger RNA and leptin protein are present in rat gastric epithelium, and that cells in the glands of the gastric fundic mucosa are immunoreactive for leptin, indicating that gastric leptin may be involved in early CCK-mediated effects activated by food intake, possibly including satiety.
Journal ArticleDOI

Leptin secretion and leptin receptor in the human stomach

TL;DR: These data provide the first evidence of the presence of leptin and leptin receptor proteins in the human stomach and suggest that gastric epithelial cells may be direct targets for leptin.
Journal ArticleDOI

Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells

TL;DR: The results demonstrate for the first time the aberrant expression of the functional thrombin receptor PAR-1 in colon cancers and its important involvement in cell proliferation and motility.
Journal ArticleDOI

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.

TL;DR: Whatever the underlying mechanism for carcinoidosis, the risk of developing fundic enterochromaffin like cell tumours in Zollinger-Ellison syndrome patients who present with MEN 1 is probably higher than was initially estimated and suggests that regular follow up of these patients is necessary.
Journal ArticleDOI

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.

TL;DR: In patients with long-standing Zollinger-Ellison syndrome who were receiving either ranitidine, omeprazole, or other antisecretory drugs for long periods of time, gastrin cell density and gastrin to somatostatin cell ratio were significantly higher than in all other patients or controls, which may indicate true gastrincell hyperplasia in relation to drug-induced profound acid inhibition.